1.
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
by Dahlöf, Björn
The Lancet (British edition), 2002-03-23, Vol.359 (9311), p.995-1003

2.
Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenol...
by Lindholm, Lars H
The Lancet (British edition), 2002-03-23, Vol.359 (9311), p.1004-1010

3.
Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (C...
by Hansson, Lennart
The Lancet (British edition), 1999, Vol.353 (9153), p.611-616

4.
Greater Regression of Electrocardiographic Left Ventricular Hypertrophy During Hydrochlorothiazide Therapy in Hypertensive Patients
by Okin, Peter M.
American journal of hypertension, 2010-07, Vol.23 (7), p.786-793

5.
Relation between drug treatment and cancer in hypertensives in the Swedish Trial in Old Patients with hypertension 2: a 5-year, prospective, randomised, controlled trial
by LINDHOLM, Lars H
The Lancet (British edition), 2001, Vol.358 (9281), p.539-544

6.
Randomised trial of effects of calcium antagonists compared with diuretics and β-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) s...
by Hansson, Lennart
The Lancet (British edition), 2000, Vol.356 (9227), p.359-365

7.
Combination of the Electrocardiographic Strain Pattern and Albuminuria for the Prediction of New-onset Heart Failure in Hypertensive Patients: The LIFE Study
by Okin, Peter M.
American journal of hypertension, 2008-03, Vol.21 (3), p.273-279

8.
Lowering of blood pressure and predictors of response in patients with left ventricular hypertrophy: the LIFE study
by Kjeldsen, Sverre E
American journal of hypertension, 2000, Vol.13 (8), p.899-906

9.
Stroke Reduction in Hypertensive Adults With Cardiac Hypertrophy Randomized to Losartan Versus Atenolol: The Losartan Intervention For Endpoint Reduction in Hypertension Study
by Kizer, Jorge R
Hypertension (Dallas, Tex. 1979), 2005-01, Vol.45 (1), p.46-52

10.
Characteristics of 9194 Patients With Left Ventricular Hypertrophy: The LIFE Study
by Dahlof, Bjorn
Hypertension (Dallas, Tex. 1979), 1998-12, Vol.32 (6), p.989-997

11.
An analysis of cholesterol control and statin use in the losartan intervention for endpoint reduction in hypertension study
by Kristianson, Krister
Clinical therapeutics, 2003-04, Vol.25 (4), p.1186-1199

12.
Pulse Pressure and Effects of Losartan or Atenolol in Patients With Hypertension and Left Ventricular Hypertrophy
by Fyhrquist, Frej
Hypertension (Dallas, Tex. 1979), 2005-04, Vol.45 (4), p.580-585

13.
Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study
by Hansson, Lennart
The Lancet (British edition), 1999, Vol.354 (9192), p.1751-1756

14.
MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Commentary
by LINDHOLM, Lars H
The Lancet (British edition), 2003, Vol.361 (9374), p.2005-2016

15.
In-treatment resolution or absence of electrocardiographic left ventricular hypertrophy is associated with decreased incidence of new-onset diabetes mellitus in hypertensive patien...
by SCHILLACI, Giuseppe
Hypertension (Dallas, Tex. 1979), 2007, Vol.50 (5)

16.
Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: Losartan intervention for endpoint reduction in hypertension study. Commentary
by IBSEN, Hans
Hypertension (Dallas, Tex. 1979), 2005, Vol.45 (2), p.198-202

17.
Effect of losartan on sudden cardiac death in people with diabetes: data from the LIFE Study. Commentary
by LINDHOLM, Lars H
The Lancet (British edition), 2003, Vol.362 (9384), p.591-620

18.
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Car...
by SEVER, Peter S
The Lancet (British edition), 2003, Vol.361 (9364), p.1149-1158
